Global Prevalence and Associated Clinical Markers of Thrombocytopenia in People Living with HIV: Evidence from Meta-Analysis
Thrombocytopenia is one of the complications in human immunodeficiency virus (HIV) patients. To improve the health outcomes of patients living with HIV, it is important to understand the prevalence and pattern of associated key clinical markers globally. This meta-analysis, therefore, aimed to estim...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-10-01
|
| Series: | Clinics and Practice |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2039-7283/12/6/91 |
| _version_ | 1797460806335463424 |
|---|---|
| author | Faisal K. Alkholifi Sayed Aliul Hasan Abdi Marwa Qadri |
| author_facet | Faisal K. Alkholifi Sayed Aliul Hasan Abdi Marwa Qadri |
| author_sort | Faisal K. Alkholifi |
| collection | DOAJ |
| description | Thrombocytopenia is one of the complications in human immunodeficiency virus (HIV) patients. To improve the health outcomes of patients living with HIV, it is important to understand the prevalence and pattern of associated key clinical markers globally. This meta-analysis, therefore, aimed to estimate the pooled prevalence of and associated clinical marker of thrombocytopenia globally. Methodology: The meta-analysis was conducted as per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. All statistical analyses were conducted using Stata. Twelve full-text papers out of 454 were eligible for meta-analysis. Results: Among 6686 participants, overall pooled prevalence of thrombocytopenia was 10.90% (95% CI: 7.91, 13.88) I<sup>2</sup> = 93.62%. In addition, thrombocytopenia was more prevalent by 25.11% (95% CI: 13.33, 36.88) in patients with CD + T < 200 cells/μL, and less prevalent in patients with CD + T < 200 cells/μL 10.10% (95% CI: 7.37, 12.83), respectively. Conclusions and recommendations: This meta-analysis established the prevalence of thrombocytopenia among patients living with HIV, and that it may be more prevalent in patients with CD + T < 200 cells/μL indicating the necessity of routine screening for various haematological markers and a careful treatment plan for HIV patients. |
| first_indexed | 2024-03-09T17:10:18Z |
| format | Article |
| id | doaj.art-6b43b70896cd4795a37581bb9d9e53f7 |
| institution | Directory Open Access Journal |
| issn | 2039-7283 |
| language | English |
| last_indexed | 2024-03-09T17:10:18Z |
| publishDate | 2022-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Clinics and Practice |
| spelling | doaj.art-6b43b70896cd4795a37581bb9d9e53f72023-11-24T14:05:07ZengMDPI AGClinics and Practice2039-72832022-10-0112686787510.3390/clinpract12060091Global Prevalence and Associated Clinical Markers of Thrombocytopenia in People Living with HIV: Evidence from Meta-AnalysisFaisal K. Alkholifi0Sayed Aliul Hasan Abdi1Marwa Qadri2Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi ArabiaFaculty of Pharmacy, Al Baha University, Al Baha 1988, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan 54943, Saudi ArabiaThrombocytopenia is one of the complications in human immunodeficiency virus (HIV) patients. To improve the health outcomes of patients living with HIV, it is important to understand the prevalence and pattern of associated key clinical markers globally. This meta-analysis, therefore, aimed to estimate the pooled prevalence of and associated clinical marker of thrombocytopenia globally. Methodology: The meta-analysis was conducted as per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. All statistical analyses were conducted using Stata. Twelve full-text papers out of 454 were eligible for meta-analysis. Results: Among 6686 participants, overall pooled prevalence of thrombocytopenia was 10.90% (95% CI: 7.91, 13.88) I<sup>2</sup> = 93.62%. In addition, thrombocytopenia was more prevalent by 25.11% (95% CI: 13.33, 36.88) in patients with CD + T < 200 cells/μL, and less prevalent in patients with CD + T < 200 cells/μL 10.10% (95% CI: 7.37, 12.83), respectively. Conclusions and recommendations: This meta-analysis established the prevalence of thrombocytopenia among patients living with HIV, and that it may be more prevalent in patients with CD + T < 200 cells/μL indicating the necessity of routine screening for various haematological markers and a careful treatment plan for HIV patients.https://www.mdpi.com/2039-7283/12/6/91HIVCD < 200 cells/μLthrombocytopenia |
| spellingShingle | Faisal K. Alkholifi Sayed Aliul Hasan Abdi Marwa Qadri Global Prevalence and Associated Clinical Markers of Thrombocytopenia in People Living with HIV: Evidence from Meta-Analysis Clinics and Practice HIV CD < 200 cells/μL thrombocytopenia |
| title | Global Prevalence and Associated Clinical Markers of Thrombocytopenia in People Living with HIV: Evidence from Meta-Analysis |
| title_full | Global Prevalence and Associated Clinical Markers of Thrombocytopenia in People Living with HIV: Evidence from Meta-Analysis |
| title_fullStr | Global Prevalence and Associated Clinical Markers of Thrombocytopenia in People Living with HIV: Evidence from Meta-Analysis |
| title_full_unstemmed | Global Prevalence and Associated Clinical Markers of Thrombocytopenia in People Living with HIV: Evidence from Meta-Analysis |
| title_short | Global Prevalence and Associated Clinical Markers of Thrombocytopenia in People Living with HIV: Evidence from Meta-Analysis |
| title_sort | global prevalence and associated clinical markers of thrombocytopenia in people living with hiv evidence from meta analysis |
| topic | HIV CD < 200 cells/μL thrombocytopenia |
| url | https://www.mdpi.com/2039-7283/12/6/91 |
| work_keys_str_mv | AT faisalkalkholifi globalprevalenceandassociatedclinicalmarkersofthrombocytopeniainpeoplelivingwithhivevidencefrommetaanalysis AT sayedaliulhasanabdi globalprevalenceandassociatedclinicalmarkersofthrombocytopeniainpeoplelivingwithhivevidencefrommetaanalysis AT marwaqadri globalprevalenceandassociatedclinicalmarkersofthrombocytopeniainpeoplelivingwithhivevidencefrommetaanalysis |